Expert Available to Discuss New Warning for Botulinum Toxin Products
Rutgers UniversityHealth care professionals and patients must be aware of the amount of botulinum neurotoxin products administered to prevent the serious adverse events that have prompted the U.S. Food and Drug Administration to change safety labels on products including Botox, urges Joseph McArdle, Ph.D., a professor at the UMDNJ-New Jersey Medical School.